Private equity firm Bridgepoint surges 21% in London debut

By Julien Ponthus and Abhinav Ramnarayan

LONDON, July 21 (Reuters) - Private equity firm Bridgepoint BPTB.L saw its value rise by more than a fifth on its London stock market debut on Wednesday, reflecting investor hunger for the sector at a time when several other buyout firms are said to be considering listings.

Bridgepoint shares opened at 423 pence on the first day of trading in London, up 21% from the 350 pence per share price set for the initial public offering (IPO). By 1100 GMT they had risen further to 437 pence, up 24.1%.

The 350 pence-per-share price tag gave the group an initial market capitalisation of 2.88 billion pounds ($3.92 billion).

Bridgepoint's debut as a public company comes at a time when private equity groups, flush with cash after largely sitting out the pandemic, have embarked on a spending spree, with Britain a favoured target for acquisitions.

Banking sources have indicated that a number of other private equity firms are considering IPOs in the second half of 2021, with European infrastructure investor Antin reportedly considering a Paris listing.

"Private equity offers exposure to a non-correlated asset class – one which does not move slavishly in line with stock or bond markets – and therefore provides useful diversification across a balanced portfolio," analysts at AJ Bell said in a note.

Bridgepoint, which focuses on mid-sized deals of up to one billion euros ($1.2 billion), manages 27.4 billion euros across a range of private equity and debt funds and was formed in 2000 after a management buyout of NatWest’s private equity arm.

Its investments include Asia-inspired dining chain Itsu, cycle retailer Wiggle and Burger King's France and UK outposts.

The company sold 85.7 million new shares to raise roughly 300 million pounds, with which it plans to fund investment, assess potential acquisitions and reduce debt.

Existing shareholders sold an additional 139.7 million existing shares, bringing the initial offer size to 789 million pounds. That sets the freefloat at roughly 27% but it will rise to around 31.5% if an over-allotment option is exercised in full.

JP Morgan and Morgan Stanley were joint global co-ordinators on the deal.
Reporting by Julien Ponthus and Abhinav Ramnarayan; Editing by Kirsten Donovan

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.